Attain OTW lead
This article was originally published in The Gray Sheet
Executive Summary
Non-U.S. marketing of Model 4193 over-the-wire lead to the left ventricle of the heart for delivery of cardiac resynchronization therapy for moderate-to-severe heart failure is underway. The 4 Fr steroid-eluting device is designed to stabilize electrical performance and facilitate placement through small and medium-sized veins. The lead tip includes a silicone seal that decreases the entry of bodily fluids to the center lumen. The lead is a component of the InSync biventricular pacing system for cardiac resynchronization